The Fisher group, in collaboration with clinicians, engineers, and researchers across various institutions, is focused on applying new biomaterial technologies to address the challenges of vascularizing tissue engineered constructs. These technologies and strategies include assessment of scaffold designs, physical surface patterning, and chemical surface modification of 3D printed tissue engineering scaffolds. The development of these vascularization techniques will enable us to support the growth of artificial organs and tissues for a variety of applications ranging from congenital heart disease to craniofacial defects.
Development of tissue-engineering scaffolds to promote vessel network formation through modulation of computer aided drafting designs, 3D fabrication of biodegradable polymeric scaffolds, and chemical modification of material surfaces.
3D printing scaffolds enables control over the design, geometry, and distribution of pores that best support extensive vascularization of the construct's interior to improve the long-term outcomes of tissue engineered constructs and artificial organs.
Wang et al. Evaluating Changes in Structure and Cytotoxicity During in Vitro Degradation of 3D Printed Scaffolds. Tissue Eng. Part A (2015). DOI: /10.1089/ten.TEA.2014.0495.
Wang et al. Evaluation of the in Vitro Cytotoxicity of Cross-linked Biomaterials. Biomacromolecules (2013) 14(5): 1321-9. DOI: 10.1021/bm301962f.
Wallace et al. Validating Continuous Digital Light Processing (cDLP) Additive Manufacturing Accuracy and tissue Engineering Utility of a Dye-initiator Package. Biofabrication (2014) 6(1): 015003. DOI: 10.1088/1758-5082/6/1/015003.
Melchiorri et al. Strategies and Techniques to Enhance the in Situ Endothelialization of Small-diameter Biodegradable Polymeric Vascular Grafts. Tissue Eng. Part B (2013) 19(4): 292-307. DOI: 10.1089/ten.TEB.2012.0577.
Melchiorri et al. Contrasting Biofunctionalization Strategies for the Enhanced Endothelialization of Biodegradable Vascular Grafts. Biomacromolecules (2015) 16(2): 437-46. DOI: 10.1021/bm501853s.